GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » Short Percentage of Float

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Short Percentage of Float


View and export this data going back to 2016. Start your Free Trial

What is ExpreS2ion Biotech Holding AB Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of ExpreS2ion Biotech Holding AB's Short Percentage of Float

For the Biotechnology subindustry, ExpreS2ion Biotech Holding AB's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ExpreS2ion Biotech Holding AB's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ExpreS2ion Biotech Holding AB's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where ExpreS2ion Biotech Holding AB's Short Percentage of Float falls into.


;
;

ExpreS2ion Biotech Holding AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » Short Percentage of Float
Comparable Companies
OSTO:ONCOZ OSTO:ATORX OSTO:ACOU XSAT:NIDHOG OSTO:BIOVIC B XSAT:CHOSA OSTO:NXTCL OSTO:MODTX OSTO:2CUREX OSTO:COMBI VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, 252 25
Website
https://www.expres2ionbio.com
ExpreS2ion Biotech Holding AB is a biotechnology company that develops vaccines. It has developed a human clinical Phase III-validated technology platform, ExpreS2, for fast and efficient development and production of the active material in vaccines. The platform, under the brand GlycoX-S2, includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. Its product pipeline comprises ES2B-C001, a HER2-VLP-based vaccine in development for human breast cancer therapy; ES2B-I002, a Cytomegalovirus (CMV) vaccine; and several exploratory vaccine projects targeting pathways validated by commercial monoclonal antibody products. Geographically, the company operates in the Nordics region and also has a presence in other countries.

ExpreS2ion Biotech Holding AB Headlines

No Headlines